DEVELOPMENT AND PRECLINICAL VALIDATION OF AN IMPROVED TISSUE ENGINEERED VASCULAR GRAFT FOR USE IN CONGENITAL HEART SURGERY
$4,049,040FY2018Defense Health AgencyDOD
Research Institute At Nationwide Children'S Hospital
Research Institute At Nationwide Children'S Hospital